Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Sanofi, Regeneron's Dupixent gains expanded approval in US for certain adolescents with atopic dermatitis

firstwordpharmaMarch 12, 2019

Tag: Sanofi , Dupixent , atopic dermatitis

PharmaSources Customer Service